Seeing Is Believing
Currently out of the existing stock ratings of Ian Somaiya, 50 are a BUY (69.44%), 22 are a HOLD (30.56%).
Analyst Ian Somaiya works with a stock forecast success ratio of 65.62% fulfilled within 600.4 days on average. Previously, Ian Somaiya worked at BMO, NOMURA.
Ian Somaiya’s has documented 147 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 23-Feb-2018.
Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for BIIB (BIOGEN) at 8/1/2016. The price target of $304 was fulfilled within 1 day with a profit of $25.98 (9.34%) receiving and performance score of 93.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
205
$22.5 (12.33%)
2 years 10 months 23 days ago
3/5 (60%)
$35.09 (20.65%)
938
Hold
173
$-9.5 (-5.21%)
156
2 years 10 months 25 days ago
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
190
$7.5 (4.11%)
194
3 years 1 months 24 days ago
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
166
$-16.5 (-9.04%)
175
3 years 1 months 24 days ago
23/23 (100%)
$10.41 (6.69%)
828
Buy
155
3 years 2 months 21 days ago
7/7 (100%)
$36.79 (31.12%)
395
What Year was the first public recommendation made by Ian Somaiya?